BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21655264)

  • 1. Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model.
    Okamoto Y; Shirakashi Y; Ihara M; Urushitani M; Oono M; Kawamoto Y; Yamashita H; Shimohama S; Kato S; Hirano A; Tomimoto H; Ito H; Takahashi R
    PLoS One; 2011; 6(5):e20427. PubMed ID: 21655264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.
    Turner BJ; Atkin JD; Farg MA; Zang DW; Rembach A; Lopes EC; Patch JD; Hill AF; Cheema SS
    J Neurosci; 2005 Jan; 25(1):108-17. PubMed ID: 15634772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.
    Furukawa Y; Fu R; Deng HX; Siddique T; O'Halloran TV
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7148-53. PubMed ID: 16636274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.
    Ström AL; Shi P; Zhang F; Gal J; Kilty R; Hayward LJ; Zhu H
    J Biol Chem; 2008 Aug; 283(33):22795-805. PubMed ID: 18515363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis.
    Karch CM; Borchelt DR
    J Neurochem; 2010 Jun; 113(5):1092-100. PubMed ID: 20067574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants.
    Eum WS; Kang JH
    Mol Cells; 1999 Feb; 9(1):110-4. PubMed ID: 10102580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS.
    Ghadge GD; Sonobe Y; Camarena A; Drigotas C; Rigo F; Ling KK; Roos RP
    Neurobiol Dis; 2020 Mar; 136():104702. PubMed ID: 31837419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
    Morfini GA; Bosco DA; Brown H; Gatto R; Kaminska A; Song Y; Molla L; Baker L; Marangoni MN; Berth S; Tavassoli E; Bagnato C; Tiwari A; Hayward LJ; Pigino GF; Watterson DM; Huang CF; Banker G; Brown RH; Brady ST
    PLoS One; 2013; 8(6):e65235. PubMed ID: 23776455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The familial amyotrophic lateral sclerosis-associated A4V SOD1 mutant is not able to regulate aerobic glycolysis.
    de Holanda Paranhos L; Magalhães RSS; de Araújo Brasil A; Neto JRM; Ribeiro GD; Queiroz DD; Dos Santos VM; Eleutherio ECA
    Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130634. PubMed ID: 38788983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking an epitope of misfolded SOD1 ameliorates disease phenotype in a model of amyotrophic lateral sclerosis.
    Bakavayev S; Stavsky A; Argueti-Ostrovsky S; Yehezkel G; Fridmann-Sirkis Y; Barak Z; Gitler D; Israelson A; Engel S
    Brain; 2023 Nov; 146(11):4594-4607. PubMed ID: 37394908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions.
    Farrawell NE; Lambert-Smith IA; Warraich ST; Blair IP; Saunders DN; Hatters DM; Yerbury JJ
    Sci Rep; 2015 Aug; 5():13416. PubMed ID: 26293199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Features of Vimentin-containing Cells in Cerebrum of Tg(SOD1*G93A)1Gur Mice: A Preliminary Study on Cerebrum Endogenous Neural Precursor Cells in Amyotrophic Lateral Sclerosis.
    Tang C; Zhu L; Zhou Q; Li M; Zhu Y; Xu Z; Lu Y; Xu R
    Int J Biol Sci; 2019; 15(13):2830-2843. PubMed ID: 31853221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential effects of brain lipid binding protein in the pathogenesis of amyotrophic lateral sclerosis.
    Zhou Q; Kang Q; Chen W; Xu R
    Sci Prog; 2023; 106(3):368504231184320. PubMed ID: 37439013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation modulating elements in mutant human superoxide dismutase 1.
    Karch CM; Borchelt DR
    Arch Biochem Biophys; 2010 Nov; 503(2):175-82. PubMed ID: 20682279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perilipin 4 Protein: an Impending Target for Amyotrophic Lateral Sclerosis.
    Zhu L; Hu F; Li C; Zhang C; Hang R; Xu R
    Mol Neurobiol; 2021 Apr; 58(4):1723-1737. PubMed ID: 33242187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific changes in the immunoreactivity of Atg9A in the central nervous system of SOD1(G93A) transgenic mice.
    Lee JC; Choe SY; Cha CI
    Anat Cell Biol; 2014 Jun; 47(2):101-10. PubMed ID: 24987546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution Features and Potential Effects of Serotonin in the Cerebrum of SOD1 G93A Transgenic Mice.
    He P; He B; Li S; Chai W; Rao W; Zhu Y; Chen W; Zhang P; Zhang X; Pan H; Xu R
    eNeuro; 2022; 9(6):. PubMed ID: 36265904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of mouse SOD1 and human/mouse SOD1 chimeras.
    Seetharaman SV; Taylor AB; Holloway S; Hart PJ
    Arch Biochem Biophys; 2010 Nov; 503(2):183-90. PubMed ID: 20727846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying effects of an
    Pytte J; Flynn LL; Anderton RS; Mastaglia FL; Theunissen F; James I; Pfaff A; Koks S; Saunders AM; Bedlack R; Burns DK; Lutz MW; Siddique N; Siddique T; Roses AD; Akkari PA
    Neurol Genet; 2020 Aug; 6(4):e470. PubMed ID: 32754644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis.
    Barberio J; Lally C; Kupelian V; Hardiman O; Flanders WD
    Neurol Genet; 2023 Dec; 9(6):e200109. PubMed ID: 38045991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.